Aflibercept in diabetic macular edema refractory to previous bevacizumab: outcomes and predictors of success

July 2018, Volume 256, Issue 7, pp 1353–1354
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: June 19, 2018

Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study

June 2018, Volume 256, Issue 6, pp 1209–1210
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: May 19, 2018

Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment

May 2018, Volume 256, Issue 5, pp. 1035–1037
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: May 2, 2018

Outcomes of Patients Initially Treated with Intravitreal Bevacizumab for Central Retinal Vein Occlusion: Long-Term Follow-Up

May 2018, Volume 33, Issue 3, p.318-319
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: May 1, 2018

Aflibercept for patients with neovascular age-related macular degeneration in routine clinical practice in Germany. Twelve-month outcomes of Perseus

April 2018, Volume 10, Issue 4, pp.68602-68603
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: April 23, 2018

Letter to the Editor: Ranibizumab 0.3 mg for Persistent Diabetic Macular Edema After Recent, Frequent, and Chronic Bevacizumab: The ROTATE Trial

March 2018, Volume 49, Issue 3, p. 160
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: March 21, 2018

Re: Khurana et al.: Aflibercept for Previously Treated Macular Edema Associated with Central Retinal Vein Occlusions: 1-Year Results of the NEWTON Study (Ophthalmol Retina. 2017)

March 2018, Volume 2, Issue 3, p. e5–e6
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: March 2, 2018

Inner nuclear layer cystoid spaces are a poor prognostic factor in typical age-related macular degeneration and polypoidal choroidal vasculopathy

March 2018, Volume 256, Issue 3, pp. 627–629
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: March 1, 2018

Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome

February 2018, Volume 186, p.164–165
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: Feb 1, 2018

Comments to: Restoration of photoreceptors in eyes with diabetic macular edema.

January 2018, Volume 28, Issue 1, pp. 132-133
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: January 5, 2018

Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy

January 2018, Volume 256, Issue 1, pp. 221–223
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: January 3, 2018

Effects of photodynamic therapy plus intravitreal aflibercept with subtenon triamcinolone injections for aflibercept-resistant polypoidal choroidal vasculopathy

January 2018, Volume 256, Issue 1, pp. 233–235
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: January 3, 2018

Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Macular Edema Secondary to Vein Occlusion

December 2017, Volume 184, p.190–191
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: December 1, 2017

Comments to: Real-world outcomes of anti-VEGF treatment for retinal vein occlusion in Portugal

Nov-Dec 2017, Volume 27, Issue 6, pp. 627 - 800, e175 - e195
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: November 13, 2017

Correspondence

November 2017 - Volume 37 - Issue 11 - p e139–e141
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: November 11, 2017

Treat-and-Extend Therapy Using Aflibercept for Neovascular Age-Related Macular Degeneration: A Prospective Clinical Trial

October 2017, Volume 182, p.204–205
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: October 2, 2017

Ranibizumab versus dexamethasone implant for central retinal vein occlusion: the Ranidex study

October 2017, Volume 255, Issue 10, pp. 2073–2075
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: October 1, 2017

High-frequency aflibercept injections in persistent neovascular age-related macular degeneration

October 2017, Volume 255, Issue 10, pp. 2067–2068
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: October 1, 2017

Comment on “Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion”

September 2017, Volume 10, Issue 9, p.1481-1482
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: September 5, 2017

Correspondence

September 2017, Volume 37, Issue 9, p.e108–e110
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: September 1, 2017

Comments to: Visual and anatomic outcomes after conversion to aflibercept in neovascular age-related macular degeneration: 12-month results

Jul-Aug 2017, Volume 27, Issue 4, pp. 387 - 512, e129 - e135
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: July 25, 2017

Letter to the Editor: Aflibercept For Diabetic Macular Edema in Eyes Previously Treated With Ranibizumab And/Or Bevacizumab May Further Improve Macular Thickness

July 2017, Volume 48, Issue 7, p.528-529
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: July 5, 2017

Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA

July 2017, Volume 31, Issue 7, p.1112-1113
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: July 4, 2017

Ranibizumab versus aflibercept for macular edema due to central retinal vein occlusion: 18-month results in real-life data

July 2017, Volume 255, Issue 7, pp. 1455–1457
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: July 1, 2017

Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema

July 2017, Volume 255, Issue 7, pp. 1451–1452
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: July 1, 2017

Bun venit!

Cu entuziasm și profesionalism, Dr. Dan CĂLUGĂRU a format o echipă bine pregătită, care având la dispoziție tehnică medicală performantă, ajută la rezolvarea problemelor oftalmologice, punând întotdeauna accent pe confortul și siguranța pacienților, oferind servicii oftamologice complete la standarde înalte de calitate, atât prin experiența profesională cât și ca nivel al dotării cu aparatură. Echipa beneficiază de suportul și experiența Prof. Univ. Dr. Mihai Călugăru.

În clinica noastră se tratează peste 3000 de pacienți anual, număr în permanentă creștere, având în vedere progresul științific și tehnic de care echipa Dr. Călugăru este mereu preocupată.

Echipamentele noaste sunt furnizate de către producători consacrați în domeniu: Alcon (S.U.A), Bausch & Lomb (SUA), Blanco (Germania), Brumaba (Germania), Carl Zeiss Meditec (Germania), Spacelabs (S.U.A), Getinge (Suedia), Tomey (Japonia), Melag (Germania), Nidek (Japonia), Briot (Belgia).

Pentru operațiile de reducere a dioptriilor cu laser excimer (Lasek, Prk) nu este nevoie de analize. Pentru toate celelalte intervenții chirurgicale analizele sunt obligatorii.

Analizele necesare pentru operație:

  • Hemoleucograma
  • Coagulograma
  • Glicemie
  • Uree
  • VSH
  • AST
  • ALT
  • Bilirubina totală
  • HVB
  • HVC
  • HIV
  • Consult cardiologic
  • EKG

Pentru a reuși vindecarea unui număr cât mai mare de pacienți echipa Dr. Călugăru colaborează cu mai mulți medici specializați în oftalmologie, opticieni și optometriști, cât și cu medicii de familie din zonele învecinate.